Report cover image

Vaccine Contract Manufacturing Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Sep 27, 2024
Length 145 Pages
SKU # PROD19315150

Description

Vaccine Contract Manufacturing Market: Global Market Size, Forecast, Insights, and Competitive Landscape


The global vaccine contract manufacturing market is expected to grow at a CAGR of around 9.4% during 2025-2034. This report on global vaccine contract manufacturing market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global vaccine contract manufacturing market by segmenting the market based on process process type, vaccine type, scale of operation, service, application, end user and region. Also, detailed profiles of companies operating in the vaccine contract manufacturing market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

● Increasing Awareness
● Rising Demands of Generic Medication
● Increasing Demands of Cell and Gene Therapy

Market Challenges

● Outsourcing by Well-Established Vaccine Makers is Limited

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Process Type

● Upstream
Mammalian Expression Systems
Bacterial Expression Systems
Yeast Expression Systems
Baculovirus/Insect Expression Systems
Others
● Downstream
Fill and Finish Operations
Analytical and QC studies
Packaging

Market by Vaccine Type

● Subunit Vaccines
● Live Attenuated Vaccines
● Conjugate Vaccines
● Inactivated Vaccines
● Recombinant Vector Vaccines
● Toxoid Vaccines
● Synthetic Vaccines
● Others

Market by Scale of Operation

● Commercial
● Pre-Clinical
● Clinical

Market by Service

● Bulk Product
● Fill Finish

Market by Application

● Human Use
● Veterinary

Market by End User

● Pharmaceutical Companies
● Biotech Companies
● Others

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
Rest of Middle East & Africa

Table of Contents

145 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Vaccine Contract Manufacturing Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Vaccine Contract Manufacturing Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Vaccine Contract Manufacturing Market by Process Type
5.1. Introduction
5.2. Upstream
5.3. Downstream
6. Global Vaccine Contract Manufacturing Market by Vaccine Type
6.1. Introduction
6.2. Subunit Vaccines
6.3. Live Attenuated Vaccines
6.4. Conjugate Vaccines
6.5. Inactivated Vaccines
6.6. Recombinant Vector Vaccines
6.7. Toxoid Vaccines
6.8. Synthetic Vaccines
6.9. Others
7. Global Vaccine Contract Manufacturing Market by Scale of Operation
7.1. Introduction
7.2. Commercial
7.3. Pre-Clinical
7.4. Clinical
8. Global Vaccine Contract Manufacturing Market by Service
8.1. Introduction
8.2. Bulk Product
8.3. Fill Finish
9. Global Vaccine Contract Manufacturing Market by Application
9.1. Introduction
9.2. Human Use
9.3. Veterinary
10. Global Vaccine Contract Manufacturing Market by End User
10.1. Introduction
10.2. Pharmaceutical Companies
10.3. Biotech Companies
10.4. Others
11. Global Vaccine Contract Manufacturing Market by Region
11.1. Introduction
11.2. Europe
11.2.1. Germany
11.2.2. United Kingdom
11.2.3. France
11.2.4. Italy
11.2.5. Spain
11.2.6. Russia
11.2.7. Netherlands
11.2.8. Rest of the Europe
11.3. North America
11.3.1. United States
11.3.2. Canada
11.4. Asia Pacific
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. South Korea
11.4.5. Australia
11.4.6. Indonesia
11.4.7. Rest of the Asia Pacific
11.5. Latin America
11.5.1. Mexico
11.5.2. Brazil
11.5.3. Argentina
11.5.4. Rest of Latin America
11.6. Middle East & Africa
11.6.1. Saudi Arabia
11.6.2. Turkey
11.6.3. Iran
11.6.4. United Arab Emirates
11.6.5. Rest of Middle East & Africa
12. SWOT Analysis
13. Porter’s Five Forces
14. Market Value Chain Analysis
15. Competitive Landscape
15.1. Competitive Scenario
15.2. Company Profiles
15.2.1. Albany Molecular Research Inc
15.2.2. Merck KGaA
15.2.3. Ajinomoto Co. Inc
15.2.4. Boehringer Ingelheim
15.2.5. Catalent Inc
15.2.6. Cobra Biologics Limited (Charles River Laboratories International Inc.)
15.2.7. Cytovance Biologics Inc. (Hepalink USA Inc.)
15.2.8. Fujifilm Holdings Corporation
15.2.9. GlaxoSmithKline
15.2.10. ICON plc
15.2.11. IDT Biologika GmbH
15.2.12. Lonza Group AG
15.2.13. Merck KGaA
15.2.14. Pfizer
15.2.15. Pharmaceutical Product Development LLC
15.2.16. PRA Health Sciences Inc.
15.2.17. Recipharm
15.2.18. Serum Institute of India
List of Figures
Figure 1: Global Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 2: Global Vaccine Contract Manufacturing Market by Process Type, 2024
Figure 3: Global Vaccine Contract Manufacturing Market by Vaccine Type, 2024
Figure 4: Global Vaccine Contract Manufacturing Market by Scale of Operation, 2024
Figure 5: Global Vaccine Contract Manufacturing Market by Service, 2024
Figure 6: Global Vaccine Contract Manufacturing Market by Application, 2024
Figure 7: Global Vaccine Contract Manufacturing Market by End User, 2024
Figure 8: Global Vaccine Contract Manufacturing Market by Region, 2024
Figure 9: Global Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 10: Global Vaccine Contract Manufacturing Market by Process Type (in %), 2024 & 2034
Figure 11: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 12: Global Upstream Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 13: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 14: Global Downstream Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 15: Global Vaccine Contract Manufacturing Market by Vaccine Type (in %), 2024 & 2034
Figure 16: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 17: Global Subunit Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 18: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 19: Global Live Attenuated Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 20: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 21: Global Conjugate Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 22: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 23: Global Inactivated Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 24: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 25: Global Recombinant Vector Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 26: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 27: Global Toxoid Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 28: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 29: Global Synthetic Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 30: Global Other Vaccine Types Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 31: Global Other Vaccine Types Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 32: Global Vaccine Contract Manufacturing Market by Scale of Operation (in %), 2024 & 2034
Figure 33: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 34: Global Commercial Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 35: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 36: Global Pre-Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 37: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 38: Global Clinical Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 39: Global Vaccine Contract Manufacturing Market by Service (in %), 2024 & 2034
Figure 40: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 41: Global Bulk Product Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 42: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 43: Global Fill Finish Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 44: Global Vaccine Contract Manufacturing Market by Application (in %), 2024 & 2034
Figure 45: Global Human Use Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 46: Global Human Use Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 47: Global Veterinary Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 48: Global Veterinary Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 49: Global Vaccine Contract Manufacturing Market by End User (in %), 2024 & 2034
Figure 50: Global Pharmaceutical Companies Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 51: Global Pharmaceutical Companies Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 52: Global Biotech Companies Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 53: Global Biotech Companies Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 54: Global Other End Users Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 55: Global Other End Users Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 56: Global Vaccine Contract Manufacturing Market by Region (in %), 2024 & 2034
Figure 57: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 58: Europe Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 59: Europe Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
Figure 60: Germany Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 61: United Kingdom Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 62: France Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 63: Italy Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 64: Spain Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 65: Russia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 66: Netherlands Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 67: North America Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 68: North America Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 69: North America Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
Figure 70: United States Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 71: Canada Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 72: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 73: Asia Pacific Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 74: Asia Pacific Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
Figure 75: China Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 76: Japan Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 77: India Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 78: South Korea Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 79: Australia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 80: Indonesia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 81: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 82: Latin America Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 83: Latin America Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
Figure 84: Mexico Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 85: Brazil Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 86: Argentina Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 87: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2020-2024
Figure 88: Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2025-2034
Figure 89: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in %), 2024 & 2034
Figure 90: Saudi Arabia Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 91: Turkey Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 92: Iran Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 93: UAE Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 94: Rest of Middle East & Africa Vaccine Contract Manufacturing Market (in US$ Million), 2017-2030
Figure 95: Market Value Chain
List of Tables
Table 1: Global Vaccine Contract Manufacturing Market Portraiture
Table 2: Global Vaccine Contract Manufacturing Market by Process Type (in US$ Million), 2024 & 2034
Table 3: Global Vaccine Contract Manufacturing Market by Vaccine Type (in US$ Million), 2024 & 2034
Table 4: Global Vaccine Contract Manufacturing Market by Scale of Operation (in US$ Million), 2024 & 2034
Table 5: Global Vaccine Contract Manufacturing Market by Service (in US$ Million), 2024 & 2034
Table 6: Global Vaccine Contract Manufacturing Market by Application (in US$ Million), 2024 & 2034
Table 7: Global Vaccine Contract Manufacturing Market by End User (in US$ Million), 2024 & 2034
Table 8: Global Vaccine Contract Manufacturing Market by Region (in US$ Million), 2024 & 2034
Table 9: Europe Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
Table 10: North America Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
Table 11: Asia Pacific Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
Table 12: Latin America Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
Table 13: Middle East & Africa Vaccine Contract Manufacturing Market by Country (in US$ Million), 2024 & 2034
Table 14: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us